medical research

It’s hard to argue that any technology company has had a greater impact in the past decade than BioNTech, the mRNA-based therapeutics pioneer behind the world’s most widely-used COVID-19 vaccine.…

BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt

The COVID-19 vaccine developed by Pfizer and BioNTech now has less stringent and extreme transportation requirements than when it debuted. Originally, the mRNA-based vaccine had to be maintained at ultra-low…

Pfizer-BioNTech’s COVID-19 vaccine just got a lot easier to transport and distribute

Another COVID-19 vaccine is almost ready to begin being distributed — a single-shot inoculation made by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary. The company just released an efficacy report based…

Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data

Moderna has detailed some of the steps it’s taking to ensure that its vaccine remains effective in the face of emerging strains of the SARS-CoV-2 virus that leads to COVID-19.…

Moderna says it’s making variant-specific COVID-19 vaccines, but its existing vaccine should still work

Moderna, the biotech company behind one of the two mRNA-based vaccines currently being rolled out globally to stem the tide of COVID-19, has announced that it will pursue development programs…

Moderna is developing three new mRNA-based vaccines for seasonal flu, HIV and Nipah virus

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine, as expected after an independent panel commissioned by the administration recommended its…

FDA authorizes Moderna’s COVID-19 vaccine for emergency use

The U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the COVID-19 vaccine developed by Pfizer and its partner BioNTech, the New York Times first…

FDA grants emergency use authorization for Pfizer’s COVID-19 vaccine, distribution to begin within days

An independent panel of experts has recommended the Food and Drug Administration (FDA) approve an official Emergency Use Authorization (EUA) for the Pfizer and BioNTech COVID-19 vaccine. This means that…

FDA panel recommends approving Pfizer’s COVID-19 vaccine emergency use authorization

Google announced today it’s introducing a new search feature that will surface a list of authorized vaccines in users’ locations, as well as informational panels about each individual vaccine. The…

Google to add COVID-19 vaccine information panels to Search

Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from…

Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today

AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage…

AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy

Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes…

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store

Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative…

Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today

Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19…

Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis

Following fast on the heels of Pfizer’s announcement of its COVID-19 vaccine efficacy, Moderna is also sharing positive results from its Phase 3 trial on Monday. The biotech company says…

Moderna reports its COVID-19 vaccine is 94.5% effective in first data from Phase 3 trial

Carbon Health has raised a $100 million Series C funding round, led by Dragoneer Investment Group and including participation from prior investors Brookfield Technology Partners, DCVC and Builders VC. This…

Carbon Health raises $100 million with plans to expand pop-up clinics ahead of COVID-19 vaccination programs

The COVID-19 vaccine being developed by Pfizer and its partner BioNTech has shown to be effective blocking infection in 90 percent of participants in its Phase 3 clinical trial, the…

Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial

Primary care health tech startup Carbon Health has added a new element to its “omnichannel” healthcare approach with the launch of a new pop-up clinic model that is already live…

Carbon Health to launch 100 pop-up COVID-19 testing clinics across the US

Medtech startup uMotif has an app that allows patients to monitor themselves for treatments or drug trials, which then feeds into a platform, allowing a much faster approach to clinical…

Medtech startup uMotif raises £5M from AlbionVC, as COVID-19 accelerates remote clinical studies

The largest trial yet for a potential COVID-19 vaccine began on Monday, as drug company Moderna began providing the first of an anticipated 30,000 volunteers with shots of its candidates.…

Moderna’s 30,000-participant Phase 3 COVID-19 vaccine trial kicks off in the US

There are more promising signs from ongoing efforts to develop a vaccine that’s effective in preventing COVID-19: Two early trials, one from the University of Oxford, and one from a…

COVID-19 vaccine trials from the University of Oxford and Wuhan both show early positive results

Twins have long played a role in the world of medical research, specifically in the area of clinical trials, where they can help measure the effectiveness of a therapy by…

Unlearn.AI nabs $12M to build “digital twins” to speed up and improve clinical trials

Bay Area coronavirus testing is about to get a boost from the private sector. Mark Zuckerberg and Priscilla Chan’s philanthropic project the Chan Zuckerberg Initiative (CZI) is collaborating with UCSF…

Chan Zuckerberg Biohub and UCSF will boost Bay Area COVID-19 tests by 1,000 per day

More details have emerged about a controversial 2015 patient data-sharing arrangement between Google DeepMind and a UK National Health Service Trust which paint a contrasting picture vs the pair’s public…

Documents detail DeepMind’s plan to apply AI to NHS data in 2015

Genoox, a startup that wants to make it easier for medical professionals to use genomic data in patient care, has raised $6 million in funding. The capital includes a seed…

Genoox raises $6M to make genetic data analysis more accessible for clinics

Dr. Karim Galil was tired of losing patients to cancer. He was tired of messy medical records. And he was tired of trying to stay on top of all the…

Mendel.ai nabs $2 million to match cancer patients with the latest clinical trials

What if the drug that could effectively treat amyotrophic lateral sclerosis, the paralyzing neurological disease that skyrocketed into the public consciousness thanks to the ice bucket challenge, already exists? That’s…

BenevolentBio’s artificial intelligence could discover a better treatment for ALS